O	0	11	Conditional	Conditional	JJ	B-NP
O	12	20	deletion	deletion	NN	I-NP
O	21	23	of	of	IN	B-PP
O	24	29	Smad1	Smad1	NN	B-NP
O	30	33	and	and	CC	I-NP
O	34	39	Smad5	Smad5	NN	I-NP
O	40	42	in	in	IN	B-PP
B-Cell	43	50	somatic	somatic	JJ	B-NP
I-Cell	51	56	cells	cell	NNS	I-NP
O	57	59	of	of	IN	B-PP
O	60	64	male	male	JJ	B-NP
O	65	68	and	and	CC	I-NP
O	69	75	female	female	JJ	I-NP
B-Organ	76	82	gonads	gonad	NNS	I-NP
O	83	88	leads	lead	VBZ	B-VP
O	89	91	to	to	TO	B-PP
B-Cancer	92	102	metastatic	metastatic	JJ	B-NP
I-Cancer	103	108	tumor	tumor	NN	I-NP
O	109	120	development	development	NN	I-NP
O	121	123	in	in	IN	B-PP
O	124	128	mice	mouse	NNS	B-NP
O	128	129	.	.	.	O

O	131	134	The	The	DT	B-NP
O	135	147	transforming	transform	VBG	I-NP
O	148	154	growth	growth	NN	I-NP
O	155	161	factor	factor	NN	I-NP
O	162	166	beta	beta	NN	I-NP
O	167	168	(	(	(	O
O	168	175	TGFbeta	TGFbeta	NN	B-NP
O	175	176	)	)	)	O
O	177	183	family	family	NN	B-NP
O	184	187	has	have	VBZ	B-VP
O	188	196	critical	critical	JJ	B-NP
O	197	202	roles	role	NNS	I-NP
O	203	205	in	in	IN	B-PP
O	206	209	the	the	DT	B-NP
O	210	220	regulation	regulation	NN	I-NP
O	221	223	of	of	IN	B-PP
O	224	233	fertility	fertility	NN	B-NP
O	233	234	.	.	.	O

O	235	237	In	In	IN	B-PP
O	238	246	addition	addition	NN	B-NP
O	246	247	,	,	,	O
O	248	251	the	the	DT	B-NP
O	252	264	pathogenesis	pathogenesis	NN	I-NP
O	265	267	of	of	IN	B-PP
O	268	272	some	some	DT	B-NP
O	273	278	human	human	JJ	I-NP
B-Cancer	279	286	cancers	cancer	NNS	I-NP
O	287	289	is	be	VBZ	B-VP
O	290	300	attributed	attribute	VBN	I-VP
O	301	303	to	to	TO	B-PP
O	304	317	misregulation	misregulation	NN	B-NP
O	318	320	of	of	IN	B-PP
O	321	328	TGFbeta	TGFbeta	NN	B-NP
O	329	337	function	function	NN	I-NP
O	338	341	and	and	CC	O
O	342	347	SMAD2	SMAD2	NN	B-NP
O	348	350	or	or	CC	I-NP
O	351	356	SMAD4	SMAD4	NN	I-NP
O	357	366	mutations	mutation	NNS	I-NP
O	366	367	.	.	.	O

O	368	373	There	There	EX	B-NP
O	374	377	are	be	VBP	B-VP
O	378	385	limited	limited	JJ	B-NP
O	386	391	mouse	mouse	NN	I-NP
O	392	398	models	model	NNS	I-NP
O	399	402	for	for	IN	B-PP
O	403	406	the	the	DT	B-NP
O	407	410	BMP	BMP	NN	I-NP
O	411	420	signaling	signaling	NN	I-NP
O	421	426	SMADs	SMAD	NNS	I-NP
O	427	428	(	(	(	O
O	428	430	BR	BR	NN	B-NP
O	430	431	-	-	HYPH	B-NP
O	431	436	SMADs	SMAD	NNS	I-NP
O	436	437	)	)	)	O
O	438	439	1	1	CD	B-NP
O	439	440	,	,	,	I-NP
O	441	442	5	5	CD	I-NP
O	442	443	,	,	,	O
O	444	447	and	and	CC	O
O	448	449	8	8	CD	B-NP
O	450	457	because	because	IN	B-PP
O	458	460	of	of	IN	I-PP
B-Developing_anatomical_structure	461	470	embryonic	embryonic	JJ	B-NP
O	471	480	lethality	lethality	NN	I-NP
O	481	484	and	and	CC	O
O	485	494	suspected	suspect	VBN	B-VP
O	495	502	genetic	genetic	JJ	B-NP
O	503	513	redundancy	redundancy	NN	I-NP
O	513	514	.	.	.	O

O	515	520	Using	Use	VBG	B-VP
B-Tissue	521	527	tissue	tissue	NN	B-NP
O	527	528	-	-	HYPH	B-NP
O	528	536	specific	specific	JJ	I-NP
O	537	545	ablation	ablation	NN	I-NP
O	546	548	in	in	IN	B-PP
O	549	553	mice	mouse	NNS	B-NP
O	553	554	,	,	,	O
O	555	557	we	we	PRP	B-NP
O	558	565	deleted	delete	VBD	B-VP
O	566	569	the	the	DT	B-NP
O	570	572	BR	BR	NN	I-NP
O	572	573	-	-	HYPH	B-NP
O	573	578	SMADs	SMAD	NNS	I-NP
O	579	583	from	from	IN	B-PP
B-Cell	584	591	somatic	somatic	JJ	B-NP
I-Cell	592	597	cells	cell	NNS	I-NP
O	598	600	of	of	IN	B-PP
B-Organ	601	608	ovaries	ovary	NNS	B-NP
O	609	612	and	and	CC	I-NP
B-Organ	613	619	testes	testis	NNS	I-NP
O	619	620	.	.	.	O

O	621	627	Single	Single	JJ	B-NP
O	628	639	conditional	conditional	JJ	I-NP
O	640	649	knockouts	knockout	NNS	I-NP
O	650	653	for	for	IN	B-PP
O	654	659	Smad1	Smad1	NN	B-NP
O	660	662	or	or	CC	I-NP
O	663	668	Smad5	Smad5	NN	I-NP
O	669	671	or	or	CC	I-NP
O	672	676	mice	mouse	NNS	I-NP
O	677	687	homozygous	homozygous	JJ	B-NP
O	688	692	null	null	NN	I-NP
O	693	696	for	for	IN	B-PP
O	697	702	Smad8	Smad8	NN	B-NP
O	703	706	are	be	VBP	B-VP
O	707	713	viable	viable	JJ	B-ADJP
O	714	717	and	and	CC	I-ADJP
O	718	725	fertile	fertile	JJ	I-ADJP
O	725	726	.	.	.	O

O	727	733	Female	Female	JJ	B-NP
O	734	740	double	double	JJ	I-NP
O	741	746	Smad1	Smad1	NN	I-NP
O	747	752	Smad5	Smad5	NN	I-NP
O	753	756	and	and	CC	O
O	757	763	triple	triple	JJ	B-NP
O	764	769	Smad1	Smad1	NN	I-NP
O	770	775	Smad5	Smad5	NN	I-NP
O	776	781	Smad8	Smad8	NN	I-NP
O	782	793	conditional	conditional	JJ	I-NP
O	794	802	knockout	knockout	NN	I-NP
O	803	807	mice	mouse	NNS	I-NP
O	808	814	become	become	VBP	B-VP
O	815	824	infertile	infertile	JJ	B-ADJP
O	825	828	and	and	CC	O
O	829	836	develop	develop	VB	B-VP
B-Cancer	837	847	metastatic	metastatic	JJ	B-NP
I-Cancer	848	857	granulosa	granulosa	NN	I-NP
I-Cancer	858	862	cell	cell	NN	I-NP
I-Cancer	863	869	tumors	tumor	NNS	I-NP
O	869	870	.	.	.	O

O	871	875	Male	Male	JJ	B-NP
O	876	882	double	double	JJ	I-NP
O	883	888	Smad1	Smad1	NN	I-NP
O	889	894	Smad5	Smad5	NN	I-NP
O	895	906	conditional	conditional	JJ	I-NP
O	907	915	knockout	knockout	NN	I-NP
O	916	920	mice	mouse	NNS	I-NP
O	921	924	are	be	VBP	B-VP
O	925	932	fertile	fertile	JJ	B-ADJP
O	933	936	but	but	CC	O
O	937	948	demonstrate	demonstrate	VBP	B-VP
B-Cancer	949	959	metastatic	metastatic	JJ	B-NP
I-Cancer	960	970	testicular	testicular	JJ	I-NP
I-Cancer	971	976	tumor	tumor	NN	I-NP
O	977	988	development	development	NN	I-NP
O	988	989	.	.	.	O

O	990	1000	Microarray	Microarray	NN	B-NP
O	1001	1009	analysis	analysis	NN	I-NP
O	1010	1019	indicated	indicate	VBD	B-VP
O	1020	1031	significant	significant	JJ	B-NP
O	1032	1043	alterations	alteration	NNS	I-NP
O	1044	1046	in	in	IN	B-PP
O	1047	1057	expression	expression	NN	B-NP
O	1058	1060	of	of	IN	B-PP
O	1061	1066	genes	gene	NNS	B-NP
O	1067	1074	related	relate	VBN	B-VP
O	1075	1077	to	to	TO	B-PP
O	1078	1081	the	the	DT	B-NP
O	1082	1089	TGFbeta	TGFbeta	NN	I-NP
O	1090	1097	pathway	pathway	NN	I-NP
O	1097	1098	,	,	,	O
O	1099	1101	as	as	RB	B-CONJP
O	1102	1106	well	well	RB	I-CONJP
O	1107	1109	as	as	IN	I-CONJP
O	1110	1115	genes	gene	NNS	B-NP
O	1116	1124	involved	involve	VBN	B-VP
O	1125	1127	in	in	IN	B-PP
O	1128	1139	infertility	infertility	NN	B-NP
O	1140	1143	and	and	CC	O
B-Cellular_component	1144	1157	extracellular	extracellular	JJ	B-NP
I-Cellular_component	1158	1164	matrix	matrix	NN	I-NP
O	1165	1175	production	production	NN	I-NP
O	1175	1176	.	.	.	O

O	1177	1182	These	These	DT	B-NP
O	1183	1187	data	datum	NNS	I-NP
O	1188	1196	strongly	strongly	RB	B-VP
O	1197	1206	implicate	implicate	VBP	I-VP
O	1207	1210	the	the	DT	B-NP
O	1211	1213	BR	BR	NN	I-NP
O	1213	1214	-	-	HYPH	B-NP
O	1214	1219	SMADs	SMAD	NNS	I-NP
O	1220	1222	as	as	IN	B-PP
O	1223	1227	part	part	NN	B-NP
O	1228	1230	of	of	IN	B-PP
O	1231	1232	a	a	DT	B-NP
O	1233	1241	critical	critical	JJ	I-NP
O	1242	1255	developmental	developmental	JJ	I-NP
O	1256	1263	pathway	pathway	NN	I-NP
O	1264	1266	in	in	IN	B-PP
B-Organ	1267	1274	ovaries	ovary	NNS	B-NP
O	1275	1278	and	and	CC	I-NP
B-Organ	1279	1285	testis	testis	NN	I-NP
O	1286	1290	that	that	WDT	B-NP
O	1290	1291	,	,	,	O
O	1292	1296	when	when	WRB	B-ADVP
O	1297	1306	disrupted	disrupt	VBN	B-VP
O	1306	1307	,	,	,	O
O	1308	1313	leads	lead	VBZ	B-VP
O	1314	1316	to	to	TO	B-PP
O	1317	1326	malignant	malignant	JJ	B-NP
O	1327	1341	transformation	transformation	NN	I-NP
O	1341	1342	.	.	.	O

